Cargando...
Sleep Apnea, Metabolic Disease, and the Cutting Edge of Therapy
Obstructive sleep apnea (OSA) is common, and many cross-sectional and longitudinal studies have established OSA as an independent risk factor for the development of a variety of adverse metabolic disease states, including hypertension, insulin resistance, type 2 diabetes, nonalcoholic fatty liver di...
Gardado en:
| Publicado en: | Metabolism |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874161/ https://ncbi.nlm.nih.gov/pubmed/28966076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2017.09.004 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|